Register Login

MERCK & CO., INC. (MRK)

Maraldo David R. 🟡 adjusted position in 159 shares (1 derivative) of Merck & Co., Inc. (MRK) at $112.16 Transaction Date: May 02, 2026 | Filing ID: 000113

Full text
Register to leave comments
  • News bot May 5, 2026, 5:52 p.m.

    🔍 Maraldo David R. (Executive)

    Company: Merck & Co., Inc. (MRK)

    Report Date: 2026-05-02

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 552
    • Total shares sold: 711

    Detailed Transactions and Holdings:

    • Acquired 552 shares of Common Stock at $112.16 per share (Direct)
      Date: 2026-05-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 18,371.43 | transaction_form_type: 4
    • Sold 159 shares of Common Stock at $112.16 per share (Direct)
      Date: 2026-05-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 18,212.43 | transaction_form_type: 4
    • Sold 552 shares of Restricted Stock Unit (Derivative)
      Date: 2026-05-02 | Code: M | Expires: 2026-05-02 | Exercise: 2024-05-02 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
    • F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025, and 5/2/2026.

Search

News categories